Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL, United States of America.
Center for Drug Evaluation and Safety [CoDES], University of Florida, Gainesville, FL, United States of America.
PLoS One. 2024 Jun 17;19(6):e0304742. doi: 10.1371/journal.pone.0304742. eCollection 2024.
Most US children with acute otitis media [AOM] receive prompt antibiotic treatment, though guidelines encourage watchful waiting. Previous systematic reviews of antibiotics versus watchful waiting have focused on symptom resolution and RCTs, limiting the assessment of serious, rare complications. We sought to evaluate these complications by including observational studies.
RCTs and observational studies that compared antibiotics to placebo or watchful waiting for pediatric clinician diagnosed AOM were identified [PubMed/MEDLINE, Embase, Cochrane Database of Systematic Reviews, Central Register of Controlled Trials, and Web of Science] and reviewed for meta-analysis. Two reviewers independently extracted study characteristics, patient characteristics, and outcomes. We assessed publication bias, study bias with ROBINS-1 and RoB-2 and used random-effects models to assess treatment effects.
24 studies were included. Antibiotics decreased the risk of acute mastoiditis [incidence 0.02%, RR 0.48, 95% CI 0.40-0.59; NNT 5,368]. This protective effect may be underestimated because of misclassification of non-suppurative conditions as AOM. Intracranial complications remained too rare to assess. Antibiotics markedly increased the risk of adverse effects [incidence 10.5%, RR 1.49, 1.27-1.73; NNH 23]. Studies used non-specific criteria for acute mastoiditis, potentially underestimating treatment effects.
Prompt antibiotic therapy reduces the risk for some AOM complications. The NNT to prevent serious, rare complications is high, while the NNH is relatively low. Large-scale population-based observational studies using real-world datasets with validated measures of severe complications are needed to improve understanding of risk factors for serious AOM complications, facilitate more selective antibiotic therapy, and optimize individual outcomes and public health.
大多数美国患有急性中耳炎(AOM)的儿童会接受及时的抗生素治疗,尽管指南鼓励观察等待。先前关于抗生素与观察等待的系统评价主要集中在症状缓解和 RCT 上,限制了对严重、罕见并发症的评估。我们通过纳入观察性研究来评估这些并发症。
我们在 [PubMed/MEDLINE、Embase、Cochrane 系统评价数据库、中央对照试验注册处和 Web of Science] 中确定了比较抗生素与安慰剂或观察等待治疗儿科临床医生诊断为 AOM 的 RCT 和观察性研究,并对其进行了荟萃分析。两位审稿人独立提取研究特征、患者特征和结局。我们评估了发表偏倚、ROBINS-1 和 RoB-2 研究偏倚,并使用随机效应模型评估治疗效果。
纳入了 24 项研究。抗生素降低了急性乳突炎的风险[发生率 0.02%,RR 0.48,95%CI 0.40-0.59;NNH 5,368]。由于将非化脓性疾病误诊为 AOM,这种保护作用可能被低估了。颅内并发症仍然太少,无法评估。抗生素显著增加了不良反应的风险[发生率 10.5%,RR 1.49,1.27-1.73;NNH 23]。研究使用了非特异性的急性乳突炎标准,可能低估了治疗效果。
及时的抗生素治疗可降低某些 AOM 并发症的风险。预防严重、罕见并发症的 NNT 很高,而 NNH 相对较低。需要使用基于人群的大型观察性研究,使用真实世界的数据和经过验证的严重并发症测量标准,以更好地了解严重 AOM 并发症的危险因素,促进更有选择性的抗生素治疗,并优化个体结局和公共卫生。